Phase IIPeptide
Compound 61999
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061999
Risk Class
HIGH
Last Audit
Nov 15, 2108
Research Abstract
Peptide candidate engineered for cellular repair initiatives with automated dossier coverage.
Compound 61999 is a peptide asset inside peptide innovation track initiatives, optimized for cellular repair and tissue regeneration.
The dossier currently sits in phase ii with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-061999 with updates logged 2108-11-15.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cellular repairTissue regeneration
Nomenclature
CX-61999Peptide Program 61999
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061999
- [2] Operations Pulse • Peptide innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-61999